Qiagen (QGEN) Change in Accured Expenses (2010 - 2026)
Qiagen (QGEN) posted Change in Accured Expenses of -$13.8 million for Q1 2026, down 14.31% sequentially from -$12.1 million in Q4 2025, and up 9.39% YoY from -$12.6 million in Q1 2025.
Qiagen (QGEN) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Qiagen has reported Change in Accured Expenses for 16 years, with the latest figure at -$13.8 million in Q1 2026.
- Quarterly Change in Accured Expenses rose 9.39% year-over-year to -$13.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$41.4 million (down 878.95% YoY) and the FY2025 annual result came in at -$42.8 million, down 395.5% from the prior year.
- Change in Accured Expenses declined to -$13.8 million in Q1 2026 per QGEN's latest filing, from -$12.1 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $50.3 million in Q2 2024 and troughed at -$58.9 million in Q1 2023.
- A 5-year average of -$8.2 million and a median of -$11.5 million in 2023 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses sank 2141.52% in 2023, then surged 537.85% in 2024.
- Over 5 years, Change in Accured Expenses stood at -$53.1 million in 2022, then surged by 141.72% to $22.2 million in 2023, then plunged by 146.12% to -$10.2 million in 2024, then declined by 18.14% to -$12.1 million in 2025, then retreated by 14.31% to -$13.8 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$13.8 million, -$12.1 million, and -$31.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -249.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -48.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 12.11 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 23.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 142.00 Mn |
| 10 | Qiagen | 8.65 Bn | 8.65 Bn | - | -13.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.80 Mn |
| Mar 31, 2026 | -13.80 Mn |
| Dec 31, 2025 | -12.08 Mn |
| Dec 31, 2025 | -12.08 Mn |
| Sep 30, 2025 | -31.95 Mn |
| Sep 30, 2025 | -31.95 Mn |
| Jun 30, 2025 | 16.43 Mn |
| Jun 30, 2025 | 16.43 Mn |
| Mar 31, 2025 | -15.23 Mn |
| Mar 31, 2025 | -15.23 Mn |
| Dec 31, 2024 | -10.22 Mn |
| Dec 31, 2024 | -10.22 Mn |
| Sep 30, 2024 | -29.12 Mn |
| Sep 30, 2024 | -29.12 Mn |
| Jun 30, 2024 | 50.35 Mn |
| Jun 30, 2024 | 50.35 Mn |
| Mar 31, 2024 | -19.65 Mn |
| Mar 31, 2024 | -19.65 Mn |
| Dec 31, 2023 | 22.16 Mn |
| Dec 31, 2023 | 22.16 Mn |